Drug Patent Profile
Ibuprofen intravenous - Cumberland Pharmaceuticals
At a glance
- Drug Originator Cumberland Pharmaceuticals
- Drug Licenced by Al-Nabil; Alveda Pharma; Cardinal Health; DB Pharm Korea; GerminMED; Grifols; Insanbakti; Phebra; Piramal Critical Care; PT SOHO Industri Pharmasi; PT. ETHICA Industri Farmasi; Sandor Medicaids; Seqirus; Valmorca Laboratories; Winhealth Pharma
- Drug Class Amines; Analgesics; Antipyretics; Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
- USA Patent Applicants CUMBERLAND PHARMS
- USA Patents 15
- NDAs 1
- International Patents 56
- Patent Applications 4,375
Disclaimer
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.